ERLOTINIB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H23N3O4
Molecular Weight	393.4357
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of ERLOTINIB

Structure Search

SMILES

COCCOC1=CC2=C(C=C1OCCOC)C(NC3=CC(=CC=C3)C#C)=NC=N2

InChI

InChIKey=AAKJLRGGTJKAMG-UHFFFAOYSA-N

InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)

HIDE SMILES / InChI

Molecular Formula	C22H23N3O4
Molecular Weight	393.4357
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:26:04 UTC 2023` Edited by `admin` on `Fri Dec 15 16:26:04 UTC 2023`
Record UNII	J4T82NDH7E
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ERLOTINIB

Official Name

English

N-(3-ETHYNYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)QUINAZOLIN-4-AMINE

Systematic Name

English

CP-358774

Code

English

RG-1415

Code

English

ERLOTINIB [EMA EPAR]

Common Name

English

R-1415

Code

English

Erlotinib [WHO-DD]

Common Name

English

CP-35877401

Code

English

ERLOTINIB [MI]

Common Name

English

erlotinib [INN]

Common Name

English

ERLOTINIB [VANDF]

Common Name

English

4-QUINAZOLINAMINE, N-(3-ETHYNYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-

Systematic Name

English

CP-358,774

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C2167

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

NDF-RT

N0000175605

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

WHO-VATC

QL01XE03

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

WHO-ATC

L01XE03

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

LIVERTOX

NBK548407

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

NCI_THESAURUS

C129825

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

NDF-RT

N0000175076

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

EMA ASSESSMENT REPORTS

TARCEVA (AUTHORIZED: PANCREATIC NEOPLASMS)

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

EMA ASSESSMENT REPORTS

TARCEVA (AUTHORISED: CARCINOMA, NON-SMALL-CELL LUNG)

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

Code System Code Type Description

DRUG BANK

DB00530

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

DAILYMED

J4T82NDH7E

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

CAS

183321-74-6

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

ChEMBL

CHEMBL553

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

IUPHAR

4920

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

NCI_THESAURUS

C65530

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

INN

8133

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

SMS_ID

100000089519

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

DRUG CENTRAL

1045

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

MERCK INDEX

m5000

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

Merck Index

EPA CompTox

DTXSID8046454

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

CHEBI

53509

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

HSDB

8082

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

MESH

C400278

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

LACTMED

Erlotinib

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

CHEBI

114785

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

WIKIPEDIA

ERLOTINIB

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

FDA UNII

J4T82NDH7E

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

RXCUI

337525

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

RxNorm

EVMPD

SUB16423MIG

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

PUBCHEM

176870

Created by admin on Fri Dec 15 16:26:04 UTC 2023 , Edited by admin on Fri Dec 15 16:26:04 UTC 2023

PRIMARY

Related Record Type Details


					482M00274D

OCT-2

TRANSPORTER -> SUBSTRATE


					76UB6O122H

ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2

TRANSPORTER -> INHIBITOR


					5840721PJZ

OAT-2

TRANSPORTER -> SUBSTRATE

Amount:


					DA87705X9K

ERLOTINIB HYDROCHLORIDE

SALT/SOLVATE -> PARENT


					ONY583280Z

OCT-1

TRANSPORTER -> SUBSTRATE


					22ES734693

MULTIDRUG RESISTANCE PROTEIN 1

TRANSPORTER -> INHIBITOR

Amount:


					RO03J093CP

EPIDERMAL GROWTH FACTOR RECEPTOR

TARGET -> INHIBITOR


					4007E25Z4Z

OCT-3

TRANSPORTER -> INHIBITOR


					482M00274D

OCT-2

TRANSPORTER -> INHIBITOR


					ZWJ2Y6JZWY

OAT-3

TRANSPORTER -> SUBSTRATE

Related Record Type Details


					X78J9Z28DQ

CP-373420

METABOLITE ACTIVE -> PARENT

Interaction Type:

MAJOR

Qualification:

FECAL; URINE

Amount:


					8WJW95YV4U

ERLORTINIB HEPATOTOXIC GUINONEIMINE

METABOLITE -> PARENT


					EBL2O556JZ

CP-373413

METABOLITE -> PARENT

Interaction Type:

MAJOR

Qualification:

FECAL; URINE

Amount:


					92T0F45VE1

CP-373943

METABOLITE -> PARENT

Interaction Type:

MAJOR


					8XM9WDB2RD

2-ETHYNYL-4-((6-(2-HYDROXYETHOXY)-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YL)AMINO)PHENOL

METABOLITE -> PARENT

Interaction Type:

MINOR

Qualification:

FECAL


					X0JH558S7E

CP-457493

METABOLITE -> PARENT

Interaction Type:

MAJOR

Qualification:

FECAL

Amount:


					X0JH558S7E

CP-457493

METABOLITE -> PARENT


					92T0F45VE1

CP-373943

METABOLITE -> PARENT

Interaction Type:

MAJOR

Qualification:

FECAL; URINE

Amount:


					3OAQ9M99Y2

CP-394356

METABOLITE -> PARENT


					X0JH558S7E

CP-457493

METABOLITE -> PARENT

Interaction Type:

MAJOR

Qualification:

URINE

Amount:


					JBW9REG8TL

2-(3-((6-(2-HYDROXYETHOXY)-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YL)AMINO)PHENYL)ACETIC ACID

METABOLITE -> PARENT

Interaction Type:

MINOR

Qualification:

FECAL; URINE

Amount:


					NE98M1L9HG

2-(4-(3-ETHYNYLANILINO)-7-(2-METHOXYETHOXY)QUINAZOLIN-6-YL)OXYACETIC ACID

METABOLITE -> PARENT

Interaction Type:

MINOR

Qualification:

FECAL; URINE


					X78J9Z28DQ

CP-373420

METABOLITE ACTIVE -> PARENT

Interaction Type:

MAJOR


					3OAQ9M99Y2

CP-394356

METABOLITE -> PARENT

Interaction Type:

MAJOR

Qualification:

FECAL

Amount:


					EBL2O556JZ

CP-373413

METABOLITE -> PARENT

Interaction Type:

MAJOR

Related Record Type Details


					J4T82NDH7E

ERLOTINIB

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
CSF/PLASMA RATIO	BIOLOGICAL				SPECIES BIOLOGICAL